Stay updated with breaking news from 64026810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nektar Therapeutics (NASDAQ:NKTR – Get Rating) SVP Mark Andrew Wilson sold 3,136 shares of Nektar Therapeutics stock in a transaction dated Monday, May 16th. The stock was sold at an average price of $3.95, for a total value of $12,387.20. Following the completion of the transaction, the senior vice president now directly owns 117,939 shares […]
Analysts forecast that Nektar Therapeutics (NASDAQ:NKTR – Get Rating) will report $23.05 million in sales for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for Nektar Therapeutics’ earnings. The highest sales estimate is $26.60 million and the lowest is $21.29 million. Nektar Therapeutics reported sales of $28.33 million during the […]
Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Rating) have been given a consensus rating of “Hold” by the fifteen brokerages that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and four have issued a buy recommendation on the company. […]
Equities analysts expect Nektar Therapeutics (NASDAQ:NKTR – Get Rating) to post $23.38 million in sales for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Nektar Therapeutics’ earnings, with the highest sales estimate coming in at $26.60 million and the lowest estimate coming in at $21.29 million. Nektar Therapeutics posted sales of […]
Brokerages predict that Nektar Therapeutics (NASDAQ:NKTR – Get Rating) will report earnings of ($0.79) per share for the current quarter, Zacks reports. Six analysts have made estimates for Nektar Therapeutics’ earnings. The lowest EPS estimate is ($0.89) and the highest is ($0.66). Nektar Therapeutics reported earnings per share of ($0.68) during the same quarter last […]